James S. Burns
James S. Burns, a co-Founder of MedPointe and former MedPointe President, retired from the Company in November 2003, after having served over MedPointe’s first two years as one of its principal executives. Prior to MedPointe’s
completion of the leveraged buyout of the Healthcare Business of Carter-Wallace Inc., Mr. Burns was a co-Founder of MedPointe Capital Partners, LLC, the private equity group that identified the acquisition target and arranged for its $500 million financing. His contributions were vital to the formation of the Company and to its early success as an emerging specialty pharmaceutical company. He remains a substantial shareholder in the Company.
Prior to founding MedPointe, Mr. Burns was Vice Chairman of HealthCare Investment Corporation; Founder, Chairman and CEO of Osiris Therapeutics, Inc.; a Group President of Becton, Dickinson and Company; and a Partner at Booz-Allen & Hamilton, Inc.
Mr. Burns is Vice Chairman of the Maryland Technology Development Corporation, a Trustee of the University of Maryland Biotechnology Institute and a Director of the American Type Culture Collection. He earned his B.S. and M.S. degrees in Biological Sciences from the University of Illinois and an MBA degree from DePaul University.